This protocol is judged by an institutional evaluation board, an unbiased group that opinions any clinical trials involving human beings. If a review involves a Timetable I drug, when the board approves the protocol as ethical, the researchers must apply for an investigational new drug (IND) range through the FDA.“It’s vital that you keep in mi